Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma
Adoptive chimeric antigen receptor (CAR) T cells designed to recognize specific tumor antigens have shown promising results in cancer therapy. While CAR T cell therapy has demonstrated notable clinical effectiveness for hematologic disease, efforts to develop therapies for solid tumors, including gl...
Main Authors: | Shuchang Zhou, Han Sun, Sun Il Choi, Jinlong Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-09-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/28/9/10.31083/j.fbl2809206 |
Similar Items
-
Prospective approaches to enhancing CAR T cell therapy for glioblastoma
by: Sun Il Choi, et al.
Published: (2022-10-01) -
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
by: Kun Ma, et al.
Published: (2023-11-01) -
Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
by: Rebecca Kringel, et al.
Published: (2023-07-01) -
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression
by: Andrew S. Luksik, et al.
Published: (2023-02-01) -
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
by: Kristen D. Pawlowski, et al.
Published: (2023-12-01)